Wachtell, Lipton, Rosen & Katz served as legal advisor to AbbVie, while Ropes & Gray served as legal advisor to ImmunoGen. AbbVie Inc. (NYSE: ABBV) and...
AbbVie’s Acquisition of ImmunoGen
MACOM’s $125 million Acquisition of the RF Business of Wolfspeed
Ropes & Gray advised MACOM on the deal, and Smith Anderson advised Wolfspeed. MACOM Technology Solutions Holdings, Inc. (NASDAQ: MTSI) announced that it has entered into a...
TCR² Therapeutics’ Agreement with Adaptimmune Therapeutics
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
NEUCA’s Partnership with OncoBay
Pillsbury Winthrop Shaw Pittman LLP advised NEUCA Group on the deal while Ropes & Gray advised Moffitt Cancer Center and OncoBay Clinical. NEUCA Group, the parent...
Clinscience’s Investment in OncoBay
Ropes & Gray advised Moffitt Cancer Center and OncoBay Clinical on the deal. OncoBay obtained an investment from Clinscience, a global clinical research organization based in Warsaw,...
CANbridge Pharmaceuticals’ License Agreement with UMass Chan Medical School
Ropes & Gray represented CANbridge Pharmaceuticals on the deal. CANbridge Pharmaceuticals, a China-based biopharmaceutical company, announced its exclusive worldwide license agreement with UMass Chan Medical School relating...
HotSpot Therapeutics’ Global Strategic Collaboration with AbbVie
Ropes & Gray advised HotSpot Therapeutics on the deal. HotSpot Therapeutics announced an exclusive, worldwide collaboration and option to license agreement with AbbVie for HotSpot’s new class...
Dessert Holdings’ Acquisition of Dianne’s Fine Desserts
Ropes & Gray advised Dessert Holdings, while Katten Muchin Rosenman represented Dianne’s in the transaction. Dessert Holdings announced its acquisition of Dianne’s Fine Desserts, a provider...
Intrinsic Medicine’s Business Combination Agreement with Phoenix Biotech Acquisition Corp.
Ropes & Gray advised Intrinsic, while Goodwin Procter advised PBAX on the deal. Intrinsic Medicine, Inc., a therapeutics company leveraging human milk biology to transform Gut-Brain...
Dessert Holdings’ Acquisition of Steven Charles
Ropes & Gray advised Bain Capital Private Equity and Dessert Holdings, while Davis Graham & Stubbs advised Steven Charles on the deal. Dessert Holdings, North America’s...
Takeda’s Collaboration With JCR Pharmaceuticals
Ropes & Gray advised Takeda Pharmaceutical Company Limited in the deal. Takeda Pharmaceutical Company Limited announced an exclusive collaboration and license agreement with JCR Pharmaceuticals Co.,...
Adaptimmune’s Collaboration with Genentech
Ropes & Gray represented Adaptimmune in the deal. Adaptimmune signed its strategic collaboration with Roche Group’s Genentech Inc. to research, develop and commercialize cancer-target allogeneic T-cell...